Patient Reported Outcomes Burdens and Experiences - Phase 3

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201 ·Status: COMPLETED ·Phase: PHASE2

Quality of Life Study of Helixate NexGen

NCT01053715 ·Status: COMPLETED

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

NCT03185897 ·Status: COMPLETED

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313 ·Status: RECRUITING

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

NCT01988532 ·Status: COMPLETED

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab

NCT06104826 ·Status: NOT_YET_RECRUITING

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

NCT03938792 ·Status: COMPLETED ·Phase: PHASE3

Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia

NCT06191068 ·Status: COMPLETED

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

NCT02319070 ·Status: COMPLETED

Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

NCT03932201 ·Status: ACTIVE_NOT_RECRUITING

Prospective Biomarkers of Bone Metabolism in Hemophilia A

NCT02306694 ·Status: COMPLETED ·Phase: PHASE3

Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures

NCT03361137 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Genetic Susceptibility to Factor VIII Inhibitors

NCT00344435 ·Status: COMPLETED

Emicizumab in Patients With Acquired Hemophilia A

NCT05345197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130 ·Status: COMPLETED

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

NCT05437211 ·Status: COMPLETED ·Phase: NA

PF-06741086 Long-term Treatment in Severe Hemophilia

NCT03363321 ·Status: COMPLETED ·Phase: PHASE2

He-move-philia, Lifestyle Intervention for Patients With Hemophilia

NCT05608863 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

NCT02622321 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

NCT04165135 ·Status: COMPLETED